Molecules marstacimab to ranibizumab
100 molecules with a full cross-agency decision record, part of 534 published in total.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| marstacimab | 13 | 12 | Antihemorrhagics |
| mavacamten | 17 | 13 | Cardiac therapy |
| melatonin | 35 | 8 | Psycholeptics |
| mepolizumab | 59 | 15 | Obstructive airway diseases |
| mercaptamine | 17 | 7 | Ophthalmologicals |
| mesalazine | 27 | 6 | Antidiarrheals / intestinal anti-inflammatories |
| metformin | 13 | 5 | Diabetes |
| metformin / sitagliptin | 32 | 6 | Diabetes |
| metformin / vildagliptin | 9 | 5 | Diabetes |
| methotrexate | 38 | 5 | Immunosuppressants |
| methylnaltrexone | 13 | 7 | Laxatives |
| methylphenidate | 23 | 6 | Psychoanaleptics |
| metreleptin | 14 | 9 | Other alimentary tract and metabolism |
| midazolam | 30 | 9 | Psycholeptics |
| midostaurin | 22 | 11 | Antineoplastics |
| migalastat | 19 | 9 | Other alimentary tract and metabolism |
| miglustat | 21 | 6 | Other alimentary tract and metabolism |
| mirabegron | 15 | 10 | Urologicals |
| mirikizumab | 24 | 12 | Immunosuppressants |
| mogamulizumab | 15 | 11 | Antineoplastics |
| molnupiravir | 8 | 6 | Antivirals |
| montelukast | 13 | 4 | Obstructive airway diseases |
| morphine | 21 | 4 | Analgesics |
| mosunetuzumab | 10 | 7 | Antineoplastics |
| moxifloxacin | 12 | 4 | Antibacterials |
| nalmefene | 9 | 7 | Other nervous system |
| naloxone | 11 | 6 | Other therapeutic products |
| naproxen | 16 | 5 | Other gynecologicals |
| natalizumab | 33 | 12 | Immunosuppressants |
| nemolizumab | 18 | 11 | Other dermatologicals |
| neratinib | 11 | 10 | Antineoplastics |
| netupitant / palonosetron | 8 | 6 | Antiemetics |
| nicotine | 46 | 4 | Other nervous system |
| nilotinib | 11 | 5 | Antineoplastics |
| nintedanib | 49 | 15 | Antineoplastics |
| niraparib | 42 | 15 | Antineoplastics |
| nirmatrelvir / ritonavir | 15 | 11 | Antivirals |
| nirsevimab | 19 | 10 | Immune sera and immunoglobulins |
| nitisinone | 14 | 7 | Other alimentary tract and metabolism |
| nivolumab | 264 | 15 | Antineoplastics |
| nivolumab / relatlimab | 8 | 7 | Antineoplastics |
| obinutuzumab | 37 | 12 | Antineoplastics |
| ocrelizumab | 28 | 12 | Immunosuppressants |
| ocriplasmin | 7 | 5 | Ophthalmologicals |
| octreotide | 15 | 5 | Pituitary and hypothalamic hormones |
| odevixibat | 24 | 13 | Bile and liver therapy |
| ofatumumab | 22 | 12 | Immunosuppressants |
| olanzapine | 15 | 5 | Psycholeptics |
| olaparib | 114 | 15 | Antineoplastics |
| olipudase alfa | 11 | 8 | Other alimentary tract and metabolism |
| omalizumab | 43 | 12 | Obstructive airway diseases |
| omaveloxolone | 15 | 10 | Other nervous system |
| osilodrostat | 14 | 11 | Systemic corticosteroids |
| osimertinib | 65 | 14 | Antineoplastics |
| oxybutynin | 9 | 6 | Urologicals |
| oxycodone | 22 | 5 | Analgesics |
| ozanimod | 24 | 12 | Immunosuppressants |
| paclitaxel | 24 | 6 | Antineoplastics |
| palbociclib | 29 | 13 | Antineoplastics |
| paliperidone | 18 | 6 | Psycholeptics |
| palonosetron | 8 | 4 | Antiemetics |
| palopegteriparatide | 11 | 8 | Calcium homeostasis |
| pancreatic | 7 | 4 | Digestives |
| panitumumab | 11 | 6 | Antineoplastics |
| paracetamol | 106 | 4 | Analgesics |
| pasireotide | 10 | 5 | Pituitary and hypothalamic hormones |
| patiromer | 16 | 9 | Other therapeutic products |
| patisiran | 11 | 7 | Other nervous system |
| pazopanib | 14 | 7 | Antineoplastics |
| pegcetacoplan | 33 | 16 | Ophthalmologicals |
| pegfilgrastim | 20 | 6 | Immunostimulants |
| peginterferon alfa-2a | 16 | 6 | Immunostimulants |
| pegunigalsidase alfa | 9 | 9 | Other alimentary tract and metabolism |
| pegvaliase | 12 | 7 | Other alimentary tract and metabolism |
| pegvisomant | 16 | 8 | Pituitary and hypothalamic hormones |
| pegzilarginase | 7 | 7 | Other alimentary tract and metabolism |
| pembrolizumab | 371 | 15 | Antineoplastics |
| pemetrexed | 27 | 6 | Antineoplastics |
| pemigatinib | 14 | 12 | Antineoplastics |
| perampanel | 24 | 8 | Antiepileptics |
| pertuzumab | 32 | 13 | Antineoplastics |
| pertuzumab / trastuzumab | 13 | 7 | Antineoplastics |
| phenylbutyrate | 7 | 4 | Other alimentary tract and metabolism |
| pioglitazone | 7 | 4 | Diabetes |
| pirfenidone | 15 | 8 | Immunosuppressants |
| pirtobrutinib | 20 | 14 | Antineoplastics |
| pitolisant | 22 | 11 | Other nervous system |
| polatuzumab vedotin | 23 | 13 | Antineoplastics |
| pomalidomide | 24 | 10 | Immunosuppressants |
| ponatinib | 14 | 9 | Antineoplastics |
| posaconazole | 24 | 7 | Antimycotics |
| pralsetinib | 13 | 12 | Antineoplastics |
| prasugrel | 15 | 6 | Antithrombotics |
| pregabalin | 12 | 6 | Analgesics |
| propranolol | 14 | 6 | Beta blockers |
| quetiapine | 13 | 5 | Psycholeptics |
| racecadotril | 8 | 4 | Antidiarrheals / intestinal anti-inflammatories |
| raltegravir | 25 | 7 | Antivirals |
| ramucirumab | 31 | 9 | Antineoplastics |
| ranibizumab | 41 | 10 | Ophthalmologicals |